We are live on
!
Find out more
YU
Yale University Portfolio holdings
AUM
$2.05M
1-Year Est. Return
1.81%
This Fund
S&P 500
This Quarter
Est. Return
+30.4%
1 Year Est. Return
+1.81%
3 Year Est. Return
+33.71%
5 Year Est. Return
-16.42%
10 Year Est. Return
+71.27%
AUM
$3.48M
AUM Growth
-$36.5M
(-91%)
Cap. Flow
-$36.8M
Cap. Flow
% of AUM
-1,057.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cartesian Therapeutics
RNAC
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$14.3M |
| 2 |
Coinbase
COIN
|
+$9.97M |
| 3 |
DOO
Bombardier Recreational Products
DOO
|
+$9.01M |
| 4 |
Arvinas
ARVN
|
+$5.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.94% |
| 2 | Miscellaneous | 22.06% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
Similar funds
SGIHM
LFA
IVMX
CG
JBFJ
CLIC
GFWEX
S3G1
Yale University's Q2 2024 Portfolio in Review
As of Q2 2024, Yale University held 7 positions worth $3.48M, down 91% from $40M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Yale University withdrew a net $36.8M in Q2 2024, closing 4 positions. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $14.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, Yale University opened a new position in Cartesian Therapeutics worth $2.7M.
- Yale University's largest Q2 2024 buy was Cartesian Therapeutics: 100,000 shares worth $2.7M.
- Yale University fully exited Vanguard FTSE Emerging Markets ETF in Q2 2024, selling an estimated $14.3M.
- Yale University's ten largest holdings make up 100% of its $3.48M portfolio in Q2 2024.
- Yale University opened 1 new position and closed 4 in Q2 2024.
- Yale University's portfolio value fell 91% quarter-over-quarter to $3.48M.
Based on Yale University's 13F filing for Q2 2024, filed 14 Aug 2024.